TrialAntimicrobial agents and chemotherapy2015

Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.

Amneris E Luque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.